Correlation Between Innate Pharma and Manitou BF

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Innate Pharma and Manitou BF at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Innate Pharma and Manitou BF into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Innate Pharma and Manitou BF SA, you can compare the effects of market volatilities on Innate Pharma and Manitou BF and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Innate Pharma with a short position of Manitou BF. Check out your portfolio center. Please also check ongoing floating volatility patterns of Innate Pharma and Manitou BF.

Diversification Opportunities for Innate Pharma and Manitou BF

0.45
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Innate and Manitou is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding Innate Pharma and Manitou BF SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Manitou BF SA and Innate Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Innate Pharma are associated (or correlated) with Manitou BF. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Manitou BF SA has no effect on the direction of Innate Pharma i.e., Innate Pharma and Manitou BF go up and down completely randomly.

Pair Corralation between Innate Pharma and Manitou BF

Assuming the 90 days trading horizon Innate Pharma is expected to generate 2.41 times more return on investment than Manitou BF. However, Innate Pharma is 2.41 times more volatile than Manitou BF SA. It trades about 0.01 of its potential returns per unit of risk. Manitou BF SA is currently generating about -0.02 per unit of risk. If you would invest  195.00  in Innate Pharma on October 5, 2024 and sell it today you would lose (4.00) from holding Innate Pharma or give up 2.05% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Innate Pharma  vs.  Manitou BF SA

 Performance 
       Timeline  
Innate Pharma 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Innate Pharma are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong technical indicators, Innate Pharma is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
Manitou BF SA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Manitou BF SA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Manitou BF is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Innate Pharma and Manitou BF Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Innate Pharma and Manitou BF

The main advantage of trading using opposite Innate Pharma and Manitou BF positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Innate Pharma position performs unexpectedly, Manitou BF can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Manitou BF will offset losses from the drop in Manitou BF's long position.
The idea behind Innate Pharma and Manitou BF SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges